Construction on the Copenhagen facility started in 2002, and the facility has been fully operational since 2004. Its four floors provide over 7,500 square meters of space for analytical and development laboratories, manufacturing clean rooms, and all other areas to support our various services. In addition to delivering clinical trial material, the Copenhagen site has been approved by the EMA for manufacture of commercial supplies.
Mammalian capacity
- 2000L cGMP manufacturing (1st 2000L Thermofisher Scientific single use bioreactor in Europe)
- 2 x 750L cGMP manufacturing (stainless steel bioreactor)
- 500L cGMP manufacturing (single use bioreactor)
- 100L cGMP manufacturing (single use bioreactor)
- 100L & 330L cGMP manufacturing (stainless steel bioreactor)
- Able to perform batch, fed-batch, concentrated fed batch and continuous operation (perfusion)
- BioSep and ATF technology
- Perfusion capacity generating up to 1,000L cGMP culture per day
- cGMP cell banking
- Cell culture development laboratories with up to 15L capacity for bioprocess development and technology transfer
- 100L cell culture pilot plant (non-cGMP)
Microbial capacity
- cGMP cell banking
- Fermentation development laboratories with multiple 5L capacity for bioprocess development and technology transfer
- 20L and 100L microbial pilot plant (non-cGMP)
- 2 x 400L cGMP manufacturing
- 2 x 1,500L cGMP manufacturing
- Able to perform batch and fed-batch operation
- Methanol feeding and oxygen enrichment capabilities
- Purification of secreted, soluble proteins or inclusion bodies
Learn more about our Copenhagen facility.